*Yohei Seki¹, Kiyoko Nojima¹, Haruka Momose¹, Shuetsu Fukushi², Saya Moriyama ³, Yoshimasa Takahashi ³, Ken Maeda⁴, Tadaki Suzuki⁵, Takuo Mizukami¹, Yasuo Yoshihara⁶, Isao Hamaguchi¹ (1. Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, 2. Department of Virology 1, National Institute of Infectious Diseases, 3. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 4. Department of Veterinary Science, National Institute of Infectious Diseases, 5. Department of Pathology, National Institute of Infectious Diseases, 6. National Hospital Organization Murayama Medical Center)

*Atsuhiko Sakamoto^1,2,3, Michinobu Yoshimura², Ryota Ito², Kazunari Ishii², Ryo Ozuru², Yusuke Kurihara², Yusuke Sechi³, Aya Fujikane³, Kenji Hiromatsu², Shigeki Nabeshima³ (1. Fukuoka University, 2. Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, 3. General Medicine, Fukuoka University Hospital)

*Soichiro Kawata^1,5, Jiun-Yu Jian², Shusaku Mizukami², Shinpei Morimoto³, Meng Ling Moi⁴, Koichi Morita⁴, Setsuko Hirakura⁴, Yutaro Yamagata⁵, Hirono Otomaru⁵, Michiko Toizumi⁵, Lay Myint Yoshida⁵, Masako Moriuchi^6,1, Hiroyuki Moriuchi^6,1 (1. Department of Pediatrics, Nagasaki University Hospital, 2. Department of Immunogenetics, Institute of Tropical Medicine, Nagasaki University, 3. Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, 4. Department of Virology, Institute of Tropical Medicine, Nagasaki University, 5. Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, 6. Department of Pediatrics, Nagasaki University Graduate School of Biomedical Sciences)

*Ryota Otsubo¹, Takeharu Minamitani², Kouji Kobiyama^3,7, Ken-Ichi Imadome⁴, Ken J. Ishii^3,7, Kouhei Tumoto^5,8,9, Wataru Kamitani⁶, Teruhito Yasui¹ (1. Laboratory of Infectious Diseases and Immunity, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, 2. Toyama Prefectural Institute for Pharmaceutical Research, 3. Division of Vaccine Science, Department of Microbiology and immunology, The institute of Medical Science, The University of Tokyo, 4. Department of Advanced Medicine for Infections, National Center for Child Health and Development, 5. Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, 6. Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University, 7. Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, 8. Department of Bioengineering, School of Engineering, The University of Tokyo, 9. Institute of Medical Science, The University of Tokyo)

*Mizuki Yamamoto¹, Jin Gohda¹, Ayako Kobayashi¹, Keiko Tomita¹, Youko Hirayama¹, Naohiko Koshikawa², Motoharu Seiki³, Kentaro Semba⁴, Tetsu Akiyama⁵, Yasushi Kawaguchi⁶, Jun-ichiro Inoue⁷ (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, 2. Department of Life Science and Technology, Tokyo Institute of Technology, 3. Division of Cancer Cell Research, The Institute of Medical Science, The University of Tokyo, 4. Department of Life Science and Medical Bio-Science, Waseda University, 5. Laboratory of Molecular and Genetic Information, Institute for Quantitative Biosciences, The University of Tokyo, 6. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 7. Research Platform Office, The Institute of Medical Science, The University of Tokyo)

*Hesham Nasser¹, Rigel Suzuki², Mai Kishimoto³, Ryo Shimizu¹, the Genotype to Phenotype Japan (G2P-Japan), Akatsuki Saito⁴, Kei Sato⁵, Keita Matsuno³, Takasuke Fukuhara², Terumasa Ikeda¹ (1. Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 4. Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan, 5. Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)